ABSTRACT -Eurystatins A and B, which are produced by Streptomyces eurythermus R353-21, potently inhibited Flavobacterium prolyl endopeptidase (PED) with IC50 values of 0.004 and 0.002,ug/ml, res pectively, while no inhibition was observed against another 5 proteases, even at 100 1tg/ml. The pro tective effect of eurystatins A and B against scopolamine (3 mg/kg, i.p.)-induced amnesia in rats was evaluated by the step-through one-trial passive avoidance method. When administered i.p. 30 min prior to the acquisition trial, both eurystatins A, at 2 8 mg/kg, and B, at 4 8 mg/kg, significantly protected rats from the amnesic effect of scopolamine without behavioral side effects.
PED (EC 3.4.21.26), which exists in a variety of organs of vertebrates (1) , hydrolyzes biologically active peptides such as angiotensins I and II, bradykinin, neurotensin, oxytocin, vasopressin, etc. (2) (3) (4) (5) , al though its physiological role still remains obscure. Since vasopressin, among these peptides, has been suggested to be deeply involved in the process of learning and memory in animal experiments (6-9), Yoshimoto et al. synthesized a variety of PED inhibitors and demon strated a probable relationship between their PED in hibition in vitro and anti-amnesic activity in vivo (10) . In addition, a significant elevation of PED activity has recently been observed in the brain of patients with Alzheimer's disease (11) . Therefore, the discovery of specific PED inhibitors is considered to be of great value in studies on the physiological role of PED.
In our systematic search for new PED inhibitors from microbial metabolites, eurystatins A and B were found to be produced by S. eurythermus R353-21, a soil micro organism collected in India. The molecular formulas of eurystatins A and B were determined to be C23H38N405 and C24H40N405, respectively, having in common a unique 13-membered ' cyclic peptide core composed of L-leucine, L-ornithine and 3(S)-amino-2 oxobutyric acid, and differing from each other in the a,/3-unsaturated fatty acid attached to the a-amino moi ety of the ornithine. The inhibitory effects of eurystatins A and B on PED and another 5 proteases and their effects on the scopolamine-induced amnesia in rats were comparatively evaluated with Z-Val-prolinal, a synthetic PED inhibitor.
The activity of PED was assayed as follows: 10,ul of 0.5 U/ml Flavobacterium PED (Flavobacterium mening osepticum origin, Seikagaku Kogyo) in 50 mM phos phate buffer (pH 7.0) or partially purified PED from whole rabbit brain and 86.5 ,u l of 100 mM phosphate buffer (pH 7.0) were mixed and preincubated for 30 min in the presence or absence of inhibitor dissolved in 75% acetonitrile (13.5 Il) . Then 25,ul of 2 mM Z-GIy Pro-pNA (Seikagaku Kogyo) in 100 mM phosphate buffer (pH 7.0) containing 30% dioxane was added and incubated for an additional 5 min at 30°C. The amount of p-nitroaniline released was colorimetrically measured at 414 nm in a microplate autoreader (Titertek Multi skan MCC/340). Thrombin (Mochida Seiyaku), plasmin (Midori Juji), trypsin (Sigma), a-chymotrypsin (Sigma) and elastase (Funakoshi Yakuhin) activities were simi larly assayed in the presence or absence of inhibitor, with the substrates H-D-Phe-Pip-Arg-pNA (Daiichi Pure Chemicals) in 100 mM Tris-HC1 buffer (pH 8.3), N-benzoyl-Phe-Val-Arg-pNA (Sigma) in 100 mM Tris HC1 buffer (pH 8.3), Na-benzoyl-Arg-pNA (Sigma) in 100 mM phosphate buffer (pH 7.6), N-benzoyl-Try pNA (Sigma) in HEPES buffer (pH 7.8) and N succinyl-Ala-Ala-Ala-pNA (Sigma) in 100 mM Tris-HC1 buffer (pH 8.8), respectively. Eurystatins A and B and Z-Val-prolinal dose-depend ently inhibited Flavobacterium PED with IC50 values of 0.004, 0.002 and 0.002 ,u g/ml, respectively, as shown in Table 1 . Interestingly, they demonstrated no inhib itory effects on thrombin, plasmin, trypsin, a-chymo trypsin and elastase even at concentrations approx. 2.5 5.0 X 104 times higher than their IC50's for PED. These results indicate that, like Z-Val-prolinal, eurystatins A and B are potent and highly specific PED inhibitors. Eurystatins A and B and Z-Val-prolinal were also found to potently inhibit partially purified rabbit brain PED with IC50 values of 0.085, 0.031 and 0.016 mg/ml, respectively. The Lineweaver-Burk plots for eurystatins A and B and Z-Val-prolinal against Flavobacterium PED assayed with Z-Gly-Pro-pNA as substrate demon strated that both eurystatins A and B inhibited the en zyme in a competitive fashion, although Z-Val-prolinal was found to be a non-competitive inhibitor (data not shown).
Anti-amnesic activity was assayed in scopolamine-in duced amnesia rats by the step-through one-trial passive avoidance method with a two-compartment apparatus (12) . The apparatus consisted of a large white compart ment (30 X 30 X 30 cm) and a small black compart ment (10 X 10 X 10 cm) which were connected with a guillotine door (6 X 6 cm). Male Wistar rats (9-week old, Japan SLC, Inc.) which were kept in separate cages throughout the experiment were used. When the animals were placed into the large compartment with the guillotine door open, they entered into the small compartment and were there given an electro-shock (40 V for 10 sec) through the steel rod floor (acquisition trial). The animals which entered into the small com partment within 5 sec were selected for drug evaluation. The learning performance, which was expressed by the step-through latency period from the large compart ment to the small one was determined 24 hr after electro-shock (retention trial). Twenty-one of 41 untreat ed animals remained in the large compartment over the entire observation period of 300 sec (latency period: 224 ± 15 sec, the mean ± S.E. of 41 rats). When the rats were treated with 3 mg/kg, i.p. of scopolamine im mediately after the electro-shock, the latency period was significantly shortened (latency period: 102 ± 13 sec, the mean ± S.E. of 46 rats), meaning that scopola mine induced loss of the memory of the electro-shock. Using this scopolamine-induced rat amnesia model, the protective effect of test compounds was examined by i.p.-administration to more than 6 rats/group 30 min prior to the acquisition trial and by statistically compar ing the latency period of the test compound group in the retention trial with that of the amnesia control group treated with only scopolamine (3 mg/kg, i.p.) us ing Student's t-test.
As shown in Fig. 1 , both eurystatins A and B at the doses of I to 8 mg/kg, i.p. dose-dependently protected rats from the scopolamine-induced amnesia. The num ber of rats showing the latency period of 300 sec (cut off time) in the retention trial per tested animals at 1, 2, 4 and 8 mg/kg was 1/7, 3/14, 3/6 and 5/10 for eurystatin A and 2/7, 3/10, 3/6 and 3/9 for eurystatin B, respectively. A significant difference in the latency periods from that of the scopolamine-induced amnesia group was seen at 2 to 8 mg/kg for eurystatin A and at 4 to 8 mg/kg for eurystatin B. Particularly, 8 mg/kg of eurystatin A demonstrated a longer latency period (248 ± 20 sec) than the drug-naive control group (224 ± 15 sec), although there is no significant difference between them. As described above, the PED inhibitory activity of eurystatin A was twofold less than that of eurystatin B in terms of their IC50 values, while the mean latency periods of eurystatin A at all the doses tested was long er than those of eurystatin B and significant protection by eurystatin A was seen at a 2 times lower dose (2 mg/kg) than eurystatin B (4 mg/kg). These results may be due to differences in their pharmacokinetics, tissue distribution and biological stability. Z-Val-prolinal also shows anti-amnesic activity at 2 and 8 mg/kg, i.p. In separate experiments, both eurystatins A and B did not demonstrate any effect on behavior in the gross observation test or on motor activity in the locomotor test for 1 hr and at 24 hr after i.p.-administration of 8 mg/kg in rats.
Taira and Kaneto reported that some synthetic PED inhibitors such as Z-Pro-prolinal and Suc-Pro-prolinal demonstrated anti-amnesic activity in animal models probably in correlation with their PED inhibitory activ ity, suggesting that their anti-amnesic efficacy may be, at least partly, attributable to the inhibitory effect on the breakdown of vasopressin (13) . Our findings also support the working hypothesis that, like synthetic in hibitors, eurystatins A and B may exhibit anti-amnesic activity by virtue of their inhibition of PED. Their anti amnesic and other biological activities will be further examined in detail. Significant difference from the scopolamine-induced amnesia group (Scop.) by Student's t-test (*P < 0.05, **P < 0.01, ***P < 0 .001).
